229 related articles for article (PubMed ID: 11281837)
1. Recent developments in sequence selective minor groove DNA effectors.
Reddy BS; Sharma SK; Lown JW
Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837
[TBL] [Abstract][Full Text] [Related]
2. DNA minor groove alkylating agents.
Denny WA
Curr Med Chem; 2001 Apr; 8(5):533-44. PubMed ID: 11281840
[TBL] [Abstract][Full Text] [Related]
3. Sequence recognition of DNA by lexitropsins.
Goodsell DS
Curr Med Chem; 2001 Apr; 8(5):509-16. PubMed ID: 11281838
[TBL] [Abstract][Full Text] [Related]
4. Carbocyclic analogues of lexitropsin--DNA affinity and endonuclease inhibition.
Pućkowska A; Drozdowska D; Midura-Nowaczek K
Acta Pol Pharm; 2007; 64(2):115-9. PubMed ID: 17665860
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
[TBL] [Abstract][Full Text] [Related]
6. DNA recognition by lexitropsins, minor groove binding agents.
Lown JW
J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677
[TBL] [Abstract][Full Text] [Related]
7. Synthetic DNA minor groove-binding drugs.
Reddy BS; Sondhi SM; Lown JW
Pharmacol Ther; 1999 Oct; 84(1):1-111. PubMed ID: 10580832
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
Boger DL; Johnson DS; Yun W; Tarby CM
Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assay.
Hidalgo M; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
Anticancer Drugs; 1999 Mar; 10(3):295-302. PubMed ID: 10327036
[TBL] [Abstract][Full Text] [Related]
10. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
11. Carbocyclic Analogues of Distamycin and Netropsin.
Arciszewska K; Pućkowska A; Wróbel A; Drozdowska D
Mini Rev Med Chem; 2019; 19(2):98-113. PubMed ID: 30626311
[TBL] [Abstract][Full Text] [Related]
12. Mapping of DNA alkylation sites induced by adozelesin and bizelesin in human cells by ligation-mediated polymerase chain reaction.
Lee CS; Pfeifer GP; Gibson NW
Biochemistry; 1994 May; 33(19):6024-30. PubMed ID: 8180230
[TBL] [Abstract][Full Text] [Related]
13. Non-covalent ligand/DNA interactions: minor groove binding agents.
Nelson SM; Ferguson LR; Denny WA
Mutat Res; 2007 Oct; 623(1-2):24-40. PubMed ID: 17507044
[TBL] [Abstract][Full Text] [Related]
14. Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides.
Bell A; Kittler L; Löber G; Zimmer C
Invest New Drugs; 1996; 13(4):271-84. PubMed ID: 8824345
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the Factors That Dictate the Preferred Orientation of Lexitropsins in the Minor Groove of DNA.
Alniss HY; Witzel II; Semreen MH; Panda PK; Mishra YK; Ahuja R; Parkinson JA
J Med Chem; 2019 Nov; 62(22):10423-10440. PubMed ID: 31658809
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
Xie G; Gupta R; Lown JW
Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
[TBL] [Abstract][Full Text] [Related]
18. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
19. DNA interstrand cross-linking, DNA sequence specificity, and induced conformational changes produced by a dimeric analog of (+)-CC-1065.
Ding ZM; Hurley LH
Anticancer Drug Des; 1991 Nov; 6(5):427-52. PubMed ID: 1662513
[TBL] [Abstract][Full Text] [Related]
20. CBI-CDPBO1 and CBI-CDPBI1: CC-1065 analogs containing deep-seated modifications in the DNA binding subunit.
Boger DL; Yun W; Cai H; Han N
Bioorg Med Chem; 1995 Jun; 3(6):761-7. PubMed ID: 7582954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
